XML English Abstract Print


چکیده:   (15 مشاهده)
Introduction: Pseudomonas aeruginosa is a major opportunistic pathogen causing urinary tract infections (UTIs), particularly in hospitalized or immunocompromised patients. Rising antibiotic resistance highlights the urgent need for effective vaccines. PcrV and OmpE as key virulence factors of P. aeruginosa are promising targets for vaccine development. In a previous study, a multi-epitope vaccine construct consisting B- and T-cell epitopes of PcrV and OmpE from P. aeruginosa was designed using immunoinformatics tools. In the present study, the immunogenicity of the recombinant protein was assessed in a murine model.
Methods: After purification of the multi-epitope protein PcrV.OmpE using Nickel resin, different vaccine formulations including multi-epitope protein alone and admixed with alum were injected into mice through the subcutaneous route. Thereafter, the levels of systemic humoral and mucosal immune responses were investigated using ELISA method.
Results: The multi-epitope vaccine construct alone elicited strong systemic IgG and IgA responses, as well as mucosal antibody in urine as compared to the control mice (p<0.05). The addition of alum significantly boosted systemic IgG and IgA, as well as mucosal IgG antibody response as compared to the multi-epitope alone (p<0.05).
Conclusion: These results support the potential of a multi-epitope composed of PcrV and OmpE antigens for the prevention of P. aeruginosa-associated UTIs, warranting further studies on cellular immunity and protective efficacy.
متن کامل [PDF 276 kb]   (4 دریافت)    
نوع مطالعه: پژوهشي | موضوع مقاله: Vaccine development, efficacy and safety evaluation
دریافت: 1405/3/31

ارسال نظر درباره این مقاله : نام کاربری یا پست الکترونیک شما:
CAPTCHA

بازنشر اطلاعات
Creative Commons License این مقاله تحت شرایط Creative Commons Attribution-NonCommercial 4.0 International License قابل بازنشر است.

کلیه حقوق این وب سایت متعلق به Vaccine Research می باشد.

طراحی و برنامه نویسی : یکتاوب افزار شرق

© 2026 All Rights Reserved | Vaccine Research

Designed & Developed by : Yektaweb

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.